Research & Development

Long before a name is forgotten or a memory fades, a silent war is waged within the brain, and a new pharmaceutical weapon may have just arrived to fight it on its own terms. This battleground, previously invisible, is now the focus of groundbreaking research from Northwestern University, where

We are joined today by biopharma expert Ivan Kairatov to discuss a groundbreaking development in the fight against a virus that over 80% of the global population carries, often without a clue: human cytomegalovirus, or HCMV. While dormant for most, this stealthy pathogen poses a life-threatening

A comprehensive evaluation of specialized oncology care has provided definitive evidence that the rigorous process of certification directly translates into a higher standard of treatment and significantly improved patient outcomes. For individuals navigating the complexities of a hereditary breast

In the challenging landscape of pediatric oncology, researchers from St. Jude Children's Research Hospital have illuminated a new path forward with a highly promising combination therapy designed to combat atypical teratoid rhabdoid tumor (ATRT), a rare and exceptionally aggressive form of brain

With deep expertise in biopharmaceutical innovation and a sharp focus on oncology, Ivan Kairatov has been at the forefront of translating complex molecular discoveries into potential therapeutic strategies. Today, he joins us to discuss a groundbreaking study that shines a new light on one of

The longstanding quest to measure the true pace of human aging, independent of the calendar, has taken a decisive turn with the development of a biomarker that can be read from a simple urine sample. The development of the urinary microRNA (uEV-miRNA) aging clock represents a significant